Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: Congratulations and corrections

Pediatrics

Volumn 121, Issue 6, 2008, Pages 1290-1291

  Moya, Fernando ^a   Sinha, Sunil ^b   D'Agostino, Ralph B ^c  

^a New Hanover Regional Medical Center   (United States)

^b DURHAM UNIVERSITY   (United Kingdom)

^c Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; PORACTANT; SURFACTANT; LUNG SURFACTANT;

CLINICAL TRIAL; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFANT; LETTER; NEWBORN CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SAMPLE SIZE; SUBSTITUTION THERAPY; TERM BIRTH; TREATMENT OUTCOME; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NOTE; RANDOMIZED CONTROLLED TRIAL; STANDARD;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TERM BIRTH;

EID: 48949100335     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0710     Document Type: Letter

References (6)

1. Engle WA; American Academy of Pediatrics, Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008; 121(2):419-432
2. Moya FR, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005; 115(4):1018-1029
3. Sinha SK, Lacaze-Masmonteil T, Valls I, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115(4):1030-1038
4. Moya F, Sinha S, Gadzinowski J, et al. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials [published correction appears in Pediatrics. 2007;120(4):935]. Pediatrics. 2007;119(6). Available at: www.pediatrics.org/cgi/content/full/119/6/e1361
5. Moya F, Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol. 2007;34(1):145-177, viii
6. Romero EJ, Moya FR, Tuvim MJ, Alcorn JL. Interaction of an artificial surfactant in human pulmonary epithelial cells. Pediatr Pulmonol. 2005;39(2):167-177